Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299

1.

Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.

Kim WS, Choi DW, Choi SH, Heo JS, You DD, Lee HG.

J Surg Oncol. 2012 Mar;105(3):266-72. doi: 10.1002/jso.22090.

PMID:
21882202
2.

Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.

Lee JH, Lee KG, Ryou H, Jun YJ, Paik SS, Park HK, Lee KS.

Hepatogastroenterology. 2010 May-Jun;57(99-100):646-52.

PMID:
20698243
3.

Tumors of the ampulla of vater: histopathologic classification and predictors of survival.

Carter JT, Grenert JP, Rubenstein L, Stewart L, Way LW.

J Am Coll Surg. 2008 Aug;207(2):210-8. doi: 10.1016/j.jamcollsurg.2008.01.028.

PMID:
18656049
4.

Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.

Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, Shimamoto F, Sueda T.

Dig Dis Sci. 2008 Aug;53(8):2281-6.

PMID:
18095164
5.

Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.

Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Jang JY, Kim SW, Kang GH, Yoon YB.

Ann Surg Oncol. 2007 Nov;14(11):3195-201.

PMID:
17710498
6.

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP.

BMC Cancer. 2008 Jun 11;8:170. doi: 10.1186/1471-2407-8-170.

7.

Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.

Okano K, Oshima M, Yachida S, Kushida Y, Kato K, Kamada H, Wato M, Nishihira T, Fukuda Y, Maeba T, Inoue H, Masaki T, Suzuki Y.

J Surg Oncol. 2014 Aug;110(2):156-62. doi: 10.1002/jso.23600.

PMID:
24619853
8.

Assessment of the nodal status in ampullary carcinoma: the number of positive lymph nodes versus the lymph node ratio.

Sakata J, Shirai Y, Wakai T, Ajioka Y, Akazawa K, Hatakeyama K.

World J Surg. 2011 Sep;35(9):2118-24. doi: 10.1007/s00268-011-1175-7.

PMID:
21717240
9.

Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.

Todoroki T, Koike N, Morishita Y, Kawamoto T, Ohkohchi N, Shoda J, Fukuda Y, Takahashi H.

Ann Surg Oncol. 2003 Dec;10(10):1176-83.

PMID:
14654474
10.

Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.

Qiao QL, Zhao YG, Ye ML, Yang YM, Zhao JX, Huang YT, Wan YL.

World J Surg. 2007 Jan;31(1):137-43; discussion 144-6.

PMID:
17171495
11.

Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Iacono C, Verlato G, Zamboni G, Scarpa A, Montresor E, Capelli P, Bortolasi L, Serio G.

J Gastrointest Surg. 2007 May;11(5):578-88.

PMID:
17468917
12.

Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?

Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP.

Ann Surg Oncol. 2013 Feb;20(2):430-9. doi: 10.1245/s10434-012-2603-0.

PMID:
22956064
13.

Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Falconi M, Crippa S, Domínguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P.

Ann Surg Oncol. 2008 Nov;15(11):3178-86. doi: 10.1245/s10434-008-0099-4.

PMID:
18712568
14.

Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.

Winter JM, Cameron JL, Olino K, Herman JM, de Jong MC, Hruban RH, Wolfgang CL, Eckhauser F, Edil BH, Choti MA, Schulick RD, Pawlik TM.

J Gastrointest Surg. 2010 Feb;14(2):379-87. doi: 10.1007/s11605-009-1080-7.

PMID:
19911239
15.

Long-term survival and recurrence patterns in ampullary cancer.

Balachandran P, Sikora SS, Kapoor S, Krishnani N, Kumar A, Saxena R, Kapoor VK.

Pancreas. 2006 May;32(4):390-5.

PMID:
16670621
16.

Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.

Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW.

Ann Surg Oncol. 2007 Jan;14(1):50-60.

PMID:
17054003
17.

Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.

Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR.

J Surg Oncol. 2007 Mar 15;95(4):286-90.

PMID:
17326125
18.

15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.

Onkendi EO, Boostrom SY, Sarr MG, Farnell MB, Nagorney DM, Donohue JH, Kendrick ML, Reid-Lombardo KM, Harmsen WS, Que FG.

J Gastrointest Surg. 2012 Apr;16(4):682-91. doi: 10.1007/s11605-011-1808-z.

PMID:
22350721
19.

Surgical outcomes and prognostic factors for ampulla of Vater cancer.

Choi SB, Kim WB, Song TJ, Suh SO, Kim YC, Choi SY.

Scand J Surg. 2011;100(2):92-8.

PMID:
21737384
20.

Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater.

Moriya T, Kimura W, Hirai I, Mizutani M, Ma J, Kamiga M, Fuse A.

J Hepatobiliary Pancreat Surg. 2006;13(6):549-55.

PMID:
17139430
Items per page

Supplemental Content

Support Center